- Home
- ONCO vs FUSEW Comparison
ONCO vs FUSEW Comparison
Compare ONCO & FUSEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- FUSEW
- Stock Information
- Founded
- ONCO 2018
- FUSEW N/A
- Country
- ONCO United States
- FUSEW United States
- Employees
- ONCO N/A
- FUSEW N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- FUSEW EDP Services
- Sector
- ONCO Health Care
- FUSEW Technology
- Exchange
- ONCO Nasdaq
- FUSEW Nasdaq
- Market Cap
- ONCO 4.7M
- FUSEW 5.4M
- IPO Year
- ONCO 2022
- FUSEW N/A
- Fundamental
- Price
- ONCO $3.15
- FUSEW $0.21
- Analyst Decision
- ONCO
- FUSEW
- Analyst Count
- ONCO 0
- FUSEW 0
- Target Price
- ONCO N/A
- FUSEW N/A
- AVG Volume (30 Days)
- ONCO 70.5K
- FUSEW N/A
- Earning Date
- ONCO 12-09-2025
- FUSEW N/A
- Dividend Yield
- ONCO N/A
- FUSEW N/A
- EPS Growth
- ONCO N/A
- FUSEW N/A
- EPS
- ONCO N/A
- FUSEW N/A
- Revenue
- ONCO $1,326,959.00
- FUSEW N/A
- Revenue This Year
- ONCO N/A
- FUSEW N/A
- Revenue Next Year
- ONCO N/A
- FUSEW N/A
- P/E Ratio
- ONCO N/A
- FUSEW N/A
- Revenue Growth
- ONCO N/A
- FUSEW N/A
- 52 Week Low
- ONCO $2.45
- FUSEW N/A
- 52 Week High
- ONCO $251.60
- FUSEW N/A
- Technical
- Relative Strength Index (RSI)
- ONCO 43.15
- FUSEW N/A
- Support Level
- ONCO $3.48
- FUSEW N/A
- Resistance Level
- ONCO $3.99
- FUSEW N/A
- Average True Range (ATR)
- ONCO 0.22
- FUSEW 0.00
- MACD
- ONCO -0.04
- FUSEW 0.00
- Stochastic Oscillator
- ONCO 21.50
- FUSEW 0.00
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.